Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan;40(1):109-112.
doi: 10.2337/cd20-0110.

Linagliptin-Induced Arthralgia

Stefanie C Nigro  1 , Jennifer D Goldman  2
Affiliations
Case Reports

Linagliptin-Induced Arthralgia

Stefanie C Nigro et al. Clin Diabetes. 2022 Jan.
No abstract available

PubMed Disclaimer

References

    1. Naranjo CA, Busto U, Sellers EM, et al. . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245 - PubMed
    1. Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care 2007;30:1335–1343 - PubMed
    1. Kim NH, Yu T, Lee DH. The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. BioMed Res Int 2014;2014:368703. - PMC - PubMed
    1. American Diabetes Association . 2. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020;43(Suppl. 1): S98–S110 - PubMed
    1. U.S. Food and Drug Administration . FDA drug safety communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain. Available from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-c.... Accessed 5 January 2020

Publication types